0
Lung Cancer |

Risk Factors and Outcomes of Pneumonia in Lung Cancer Patients

Ye ryung Jung; Won Yeon Lee; Sang-Ha Kim; Myoung Kyu Lee; KyeChul Shin; Suk Joong Yong
Author and Funding Information

Yonsei University Wonju College of Medicine, Wonju, Republic of Korea


Chest. 2014;146(4_MeetingAbstracts):595A. doi:10.1378/chest.1994172
Text Size: A A A
Published online

Abstract

SESSION TITLE: Lung Cancer Posters II

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 29, 2014 at 01:30 PM - 02:30 PM

PURPOSE: Development of pneumonia in patients with lung cancer is common and results in increasing the mortality of patients. The aim of this study was to describe the clinical features and outcomes of patients with pneumonia and assess the risk factors for the development of pneumonia in patients with lung cancer.

METHODS: Following a retrospective review of clinical data from 2009 to 2012, total 348 patients with lung cancer admitted to a local tertiary hospital were enrolled in this study.

RESULTS: The mean age of enrolled patients was 60 ± 0.3 year(0.3) and 71% (n=247) were male. Risk factor for development of pneumonia was structural lung disease.(P = .021). Among the patients with pneumonia (60.8%, n=211), squamous cell carcinoma (37.4%, n=130) was the most common histologic type and the most frequently revealed pathogen was Klebsiella pneumoniae (19.4%, n=67). In 50.8% of the pneumonia patients, microbiologic causes were ESBL- producing K. pneumoniae, MRSA, Acinetobacter, Pseudomonas. In the multivariate analysis, predictors for the mortality in patients with pneumonia was delayed time of diagnosis, white blood cell count, and structural lung disease (P = .032, P = .013, P = .019 ). Patients with pneumonia showed hazard ratio of 3.913 (95% confidence interval, 1.653-9.265) compared to those without pneumonia in the Cox's regression analysis.

CONCLUSIONS: Structural lung disease was risk factor for the development of pneumonia and also mortality. In laboratory findings, white blood cell count was independent determinants of mortality but inflammation markers such as CRP and PCT was not.

CLINICAL IMPLICATIONS: Factors described above may assist with diagnosis of pneumonia and predict prognosis of it. And this could lead to prompt initiation of therapy and proper choice of antibiotics.

DISCLOSURE: The following authors have nothing to disclose: Ye ryung Jung, Won Yeon Lee, Sang-Ha Kim, Myoung Kyu Lee, KyeChul Shin, Suk Joong Yong

No Product/Research Disclosure Information


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543